Capital International Sarl Acquires Shares of 12,359 GE HealthCare Technologies Inc. $GEHC

Capital International Sarl acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 12,359 shares of the company’s stock, valued at approximately $1,014,000.

Several other large investors have also bought and sold shares of the company. Western Wealth Management LLC boosted its position in GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after acquiring an additional 125 shares in the last quarter. United Community Bank boosted its position in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after acquiring an additional 130 shares in the last quarter. Thoma Capital Management LLC boosted its position in GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after acquiring an additional 136 shares in the last quarter. Colonial Trust Advisors boosted its position in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after acquiring an additional 139 shares in the last quarter. Finally, Norinchukin Bank The boosted its position in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after acquiring an additional 149 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Peter J. Arduini bought 4,169 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was acquired at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares in the company, valued at approximately $100,364.54. The trade was a ? increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders bought 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $64.67 on Monday. The firm has a market cap of $29.42 billion, a PE ratio of 15.47, a P/E/G ratio of 1.46 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a fifty day simple moving average of $66.89 and a two-hundred day simple moving average of $75.52. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Analyst Ratings Changes

Several analysts have weighed in on the company. JPMorgan Chase & Co. cut their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a research report on Wednesday, April 29th. Barclays dropped their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Mizuho dropped their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.21.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.